The Marque The Marque
The Marque
About Services Profiles Press Contact

Brendan Kennedy

President & CEO

Tilray

Seattle, WA, USA

Brendan Kennedy
Paul Kempe
City & Provincial Properties Plc
Kerry Kennedy
RFK / Robert F. Kennedy Human Rights

Brendan’s Biography

Brendan Kennedy is the former Chief Executive Officer and Founder of Tilray, a global leader in medical cannabis industry. Tilray was the first GMP-certified medical cannabis producer to supply products to patients, researchers, and the medical community, earning itself the recognition of being a pioneer in cannabis research, cultivation, processing, and distribution

In 2011, along with Michael Blue and Christian Groh, Brendan Co-founded Privateer Holdings, the world’s first private equity firm that focuses on exclusive investments in legal cannabis. At Privateer, Brendan used his background of entrepreneurship and hands-on business experience to successfully lead the development of new and existing companies, origination and distribution of products, and management of operations. While he was at the helm of Privateer, the firm raised over $200 million to build a prominent and globalized portfolio of leaders in the cannabis industry.

Brendan has always had a voracious appetite for information and keen insight into technology and growth industries, both of which led him to the forefront...
Brendan Kennedy is the former Chief Executive Officer and Founder of Tilray, a global leader in medical cannabis industry. Tilray was the first GMP-certified medical cannabis producer to supply products to patients, researchers, and the medical community, earning itself the recognition of being a pioneer in cannabis research, cultivation, processing, and distribution

In 2011, along with Michael Blue and Christian Groh, Brendan Co-founded Privateer Holdings, the world’s first private equity firm that focuses on exclusive investments in legal cannabis. At Privateer, Brendan used his background of entrepreneurship and hands-on business experience to successfully lead the development of new and existing companies, origination and distribution of products, and management of operations. While he was at the helm of Privateer, the firm raised over $200 million to build a prominent and globalized portfolio of leaders in the cannabis industry.

Brendan has always had a voracious appetite for information and keen insight into technology and growth industries, both of which led him to the forefront of consultation and solutions for the venture-backed business community. Prior to co-founding Privateer, he served as the Chief Operating Officer of Silicon Valley Bank Analytics from 2010 to 2011 and as Managing Director from 2006 to 2010. In these roles, he oversaw an international team that rendered valuation opinions for a range of companies that specialize in emerging growth technology, venture capital and life science.

Brendan earned a bachelor's degree from the University of California, Berkeley, before going on to study Engineering at the University of Washington. He later earned his MBA from the Yale School of Management.
moreless

Brendan’s Newsfeed

Yahoo! News
Aphria-Tilray deal: Tilray shareholders approve tie-up with Aphria

Brendan Kennedy, CEO of Tilray, speaks on Tilray's future opportunities for growth as the company's shareholders approve a deal with Aphria.

Time
2021 TIME 100 Most Influential Companies

Tilray was honored for its pioneering work in the medicinal and recreational cannabis space. Also highlighted is Brendan Kennedy’s work, from co-founding a private-equity firm Privateer Holdings to heading north to British Columbia to launch Tilray, and ultimately its merger with Aphria to form the world’s largest cannabis company by annual revenue – more than $685 million.

View News Archive

Brendan’s Background

Tilray
President & CEO
Aug 2013 - Present
Nanaimo, CA
Tilray is the only GMP certified medical cannabis producer, serving researchers, patients, hospitals, governments and physicians around the globe in Europe, the US, Canada and Australia.
Privateer Holdings, Inc.
Executive Chairman
Jul 2018 - Dec 2020
Seattle, WA, USA
Privateer Holdings is a private equity firm that is actively shaping the remarkably promising cannabis marketplace through the development of strategic acquisitions and investments. Through a combination of acquisitions, investments, and incubation, Privateer is focused on building a portfolio of global brands that will lead, legitimize, and define the future of cannabis.
View allHide

Current Board Positions

Tilray
Board of Directors
Jan 2018 - Present
Nanaimo, CA
Tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. It is the only GMP certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in Australia, Canada, the European Union and the Americas.

Previous Board Positions

Privateer Holdings, Inc.
Board of Directors
2011 - 2019
Seattle, WA, USA
Privateer Holdings is a private equity firm that is actively shaping the remarkably promising cannabis marketplace through the development of strategic acquisitions and investments. Through a combination of acquisitions, investments, and incubation, Privateer is focused on building a portfolio of global brands that will lead, legitimize, and define the future of cannabis.

Media

Closing Bell: Aphria and Tilray merge in an all-stock deal as demand for cannabis grows
Interview
Dec 2020
New York, NY, USA
Aphria and Tilray are merging in an all-stock deal to form the largest cannabis company by revenue. Aphria CEO Irwin Simon and Tilray CEO Brendan Kennedy join ‘Closing Bell’ to talk about the growth of consumer demand for cannabis in the U.S.
The Wall Street Journal
"A CEO Tries to Navigate the Legal Cannabis Sector’s Bad Trip"
Mar 2020
New York, NY, USA
Brendan Kennedy, CEO of Privateer Holdings, Inc. and CEO of Tilray, talks with Chris Kornelis about the burgeoning legal marijuana industry and the opportunities and challenges it poses.
View allHide

Press Releases

Tilray® Receives Approvals to Expand and Commercialize Medical Cannabis Products in New Zealand
Mar 2021
Tilray, Inc., led by Brendan Kennedy, received approval from New Zealand's Ministry of Health as well as the Medicinal Cannabis Agency to bring products into the country.
Tilray® Announces Agreement with Grow Pharma to Import and Distribute Medical Cannabis Products in the United Kingdom
Feb 2021
Tilray, Inc. was given permission to bring its products into the UK and source patients in the UK with medical cannabis.

Brendan’s Education

University of Washington
MS Engineering
1994 - 1995
View allHide